{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T05:44:56Z","timestamp":1772084696509,"version":"3.50.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.mce.2011.05.016","type":"journal-article","created":{"date-parts":[[2011,6,5]],"date-time":"2011-06-05T20:49:40Z","timestamp":1307306980000},"page":"78-84","source":"Crossref","is-referenced-by-count":14,"title":["Inhibins and activins in blood: Predictors of female reproductive health?"],"prefix":"10.1016","volume":"359","author":[{"given":"David M.","family":"Robertson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2011.05.016_b0005","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1080\/07357900701829777","article-title":"A pilot study of predictive markers of chemotherapy-related amenorrhea among premenopausal women with early stage breast cancer","volume":"26","author":"Anders","year":"2008","journal-title":"Cancer Invest."},{"key":"10.1016\/j.mce.2011.05.016_b0010","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/pd.2279","article-title":"Maternal plasma inhibin A at 11\u201313 weeks of gestation in hypertensive disorders of pregnancy","volume":"29","author":"Akolekar","year":"2009","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.mce.2011.05.016_b0015","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000235878","article-title":"Maternal serum activin a at 11\u201313 weeks of gestation in hypertensive disorders of pregnancy","volume":"25","author":"Akolekar","year":"2009","journal-title":"Fetal Diagn. Ther."},{"key":"10.1016\/j.mce.2011.05.016_b0020","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/gme.0b013e3181aa1c93","article-title":"Ovarian status in healthy postmenopausal women: follow-up 12 months after transvaginal ultrasound","volume":"16","author":"Bell","year":"2009","journal-title":"Menopause"},{"key":"10.1016\/j.mce.2011.05.016_b0025","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/01.AOG.0000278570.76392.a6","article-title":"First- and second-trimester screening: detection of aneuploidies other than Down syndrome","volume":"110","author":"Breathnach","year":"2007","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.mce.2011.05.016_b0030","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1111\/j.1743-6109.2008.00921.x","article-title":"The menopausal transition \u2013 endocrinology","volume":"5","author":"Burger","year":"2008","journal-title":"J. Sex Med."},{"key":"10.1016\/j.mce.2011.05.016_b0035","doi-asserted-by":"crossref","first-page":"341","DOI":"10.33549\/physiolres.930315","article-title":"Inhibin B, follicle stimulating hormone, luteinizing hormone, and estradiol and their relationship to the regulation of follicle development in girls during childhood and puberty","volume":"52","author":"Chada","year":"2003","journal-title":"Physiol. Res."},{"key":"10.1016\/j.mce.2011.05.016_b0040","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.1210\/jc.2007-1252","article-title":"Hormonal profile in women with polycystic ovarian syndrome with or without type 1 diabetes mellitus","volume":"92","author":"Codner","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.05.016_b0045","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2265.2004.02198.x","article-title":"Evidence for increased ovarian follicular activity in girls with premature thelarche","volume":"62","author":"Crofton","year":"2005","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.mce.2011.05.016_b0050","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1046\/j.1365-2265.2003.01712.x","article-title":"Is inhibin B a potential marker of gonadotoxicity in prepubertal children treated for cancer?","volume":"58","author":"Crofton","year":"2003","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.mce.2011.05.016_b0055","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00441-005-1153-1","article-title":"TGFbeta signalling in the development of ovarian function","volume":"322","author":"Drummond","year":"2005","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.mce.2011.05.016_b0060","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1093\/humrep\/dei203","article-title":"Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography (1) as predictors of IVF outcome","volume":"20","author":"Eldar-Geva","year":"2005","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.mce.2011.05.016_b0065","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1373\/clinchem.2009.134080","article-title":"Combining biochemical and ultrasonographic markers in predicting preeclampsia: a systematic review","volume":"56","author":"Giguere","year":"2010","journal-title":"Clin. Chem."},{"key":"10.1016\/j.mce.2011.05.016_b0070","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1210\/jc.2007-0066","article-title":"Endocrine features of menstrual cycles in middle and late reproductive age and the menopausal transition classified according to the Staging of Reproductive Aging Workshop (STRAW) staging system","volume":"92","author":"Hale","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.05.016_b0075","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/gme.0b013e31816ddb6f","article-title":"Ovarian status in healthy postmenopausal women","volume":"15","author":"Healy","year":"2008","journal-title":"Menopause"},{"key":"10.1016\/j.mce.2011.05.016_b0080","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJM199311183292104","article-title":"Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors","volume":"329","author":"Healy","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mce.2011.05.016_b0085","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1210\/jc.76.5.1340","article-title":"Follicle-stimulating hormone induces dose-dependant stimulation of immunoreactive inhibin secretion during the follicular phase of the human menstrual cycle","volume":"76","author":"Hee","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.05.016_b0090","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/pd.2082","article-title":"Down syndrome serum screening also identifies an increased risk for multicystic dysplastic kidney, two-vessel cord, and hydrocele","volume":"28","author":"Hoffman","year":"2008","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.mce.2011.05.016_b0095","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.fertnstert.2008.10.042","article-title":"A prospective, comparative analysis of anti-Mullerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation","volume":"93","author":"Jayaprakasan","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.mce.2011.05.016_b0100","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1210\/jc.2003-031515","article-title":"Age-related analysis of inhibin A, inhibin B, and activin a relative to the intercycle monotropic follicle-stimulating hormone rise in normal ovulatory women","volume":"89","author":"Klein","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.05.016_b0105","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1210\/jc.2008-1818","article-title":"Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure","volume":"94","author":"Knauff","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.05.016_b0110","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1530\/rep.1.01074","article-title":"TGF-beta superfamily members and ovarian follicle development","volume":"132","author":"Knight","year":"2006","journal-title":"Reproduction"},{"key":"10.1016\/j.mce.2011.05.016_b0115","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.fertnstert.2007.07.1293","article-title":"Evaluation of anti-Mullerian hormone as a test for the prediction of ovarian reserve","volume":"90","author":"Kwee","year":"2008","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.mce.2011.05.016_b0120","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/pd.1469","article-title":"First- and second-trimester Down syndrome screening markers in pregnancies achieved through assisted reproductive technologies (ART): a FASTER trial study","volume":"26","author":"Lambert-Messerlian","year":"2006","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.mce.2011.05.016_b0125","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/pd.2387","article-title":"Early onset preeclampsia and second trimester serum markers","volume":"29","author":"Lambert-Messerlian","year":"2009","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.mce.2011.05.016_b0130","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1600-0412.1992.tb00008.x","article-title":"Inhibin as a marker for granulosa cell tumor","volume":"155","author":"Lappohn","year":"1992","journal-title":"Acta Obstet. Gynecol. Scand. Suppl."},{"key":"10.1016\/j.mce.2011.05.016_b0135","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mce.2004.02.011","article-title":"Inhibins and adult ovarian function","volume":"225","author":"Laven","year":"2004","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2011.05.016_b0140","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1210\/me.2008-0374","article-title":"Inhibin-A antagonizes TGFbeta2 signaling by down-regulating cell surface expression of the TGFbeta coreceptor betaglycan","volume":"24","author":"Looyenga","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2011.05.016_b0145","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/pd.2502","article-title":"Second and first trimester estimation of risk for Down syndrome: implementation and performance in the SAFER study","volume":"30","author":"MacRae","year":"2010","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.mce.2011.05.016_b0150","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.1210\/en.2008-1783","article-title":"Inhibin B is a more potent suppressor of rat follicle-stimulating hormone release than inhibin a in vitro and in vivo","volume":"150","author":"Makanji","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2011.05.016_b0155","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1210\/jc.81.11.4002","article-title":"Recombinant human inhibin-A administered early in the menstrual cycle alters concurrent pituitary and follicular, plus subsequent luteal, function in rhesus monkeys","volume":"81","author":"Molskness","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.05.016_b0160","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1093\/humrep\/15.7.1640","article-title":"Serum inhibin A and activin A are elevated prior to the onset of pre-eclampsia","volume":"15","author":"Muttukrishna","year":"2000","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.mce.2011.05.016_b0165","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/j.1471-0528.2004.00452.x","article-title":"Inhibin B and anti-Mullerian hormone: markers of ovarian response in IVF\/ICSI patients?","volume":"111","author":"Muttukrishna","year":"2004","journal-title":"BJOG"},{"key":"10.1016\/j.mce.2011.05.016_b0170","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1210\/jc.2005-2423","article-title":"Bone turnover across the menopause transition: correlations with inhibins and follicle-stimulating hormone","volume":"91","author":"Perrien","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.05.016_b0175","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1210\/en.2006-0848","article-title":"Inhibin A is an endocrine stimulator of bone mass and strength","volume":"148","author":"Perrien","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2011.05.016_b0180","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1210\/jc.2003-031326","article-title":"Inhibin B: a potential marker of gonadal activity in patients with anorexia nervosa during weight recovery","volume":"89","author":"Popovic","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.05.016_b0185","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/pd.2063","article-title":"Combined test+inhibin A at week 13 in contingent sequential testing: an interesting alternative for first-trimester prenatal screening for Down syndrome","volume":"28","author":"Ramos-Corpas","year":"2008","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.mce.2011.05.016_b0190","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1210\/jc.87.2.816","article-title":"Characterization of inhibin forms and their measurement by an inhibin alpha-subunit ELISA in serum from postmenopausal women with ovarian cancer","volume":"87","author":"Robertson","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.05.016_b0195","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1677\/erc.0.0110035","article-title":"Inhibin\/activin and ovarian cancer","volume":"11","author":"Robertson","year":"2004","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.mce.2011.05.016_b0200","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1097\/gme.0b013e3181735687","article-title":"A proposed classification system for menstrual cycles in the menopause transition based on changes in serum hormone profiles","volume":"15","author":"Robertson","year":"2008","journal-title":"Menopause"},{"key":"10.1016\/j.mce.2011.05.016_b0205","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1210\/jc.2008-1684","article-title":"Interrelationships between ovarian and pituitary hormones in ovulatory menstrual cycles across reproductive age","volume":"94","author":"Robertson","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.05.016_b0210","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/gme.0b013e3181f8d9e0","article-title":"Changes in serum anti-Mullerian hormone levels across the ovulatory menstrual cycle in late reproductive age","volume":"18","author":"Robertson","year":"2011","journal-title":"Menopause"},{"key":"10.1016\/j.mce.2011.05.016_b0215","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1210\/jc.2008-0567","article-title":"Anti-Mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition","volume":"93","author":"Sowers","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.05.016_b0220","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/cncr.24746","article-title":"AntiMullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivors","volume":"116","author":"Su","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.mce.2011.05.016_b0225","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1095\/biolreprod49.4.779","article-title":"Human recombinant inhibin A suppresses plasma follicle-stimulating hormone to intact levels but has no effect on luteinizing hormone in castrated rams","volume":"49","author":"Tilbrook","year":"1993","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.mce.2011.05.016_b0230","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1046\/j.1365-2265.2003.01686.x","article-title":"Inhibins and activins: clinical advances in reproductive medicine","volume":"58","author":"Tong","year":"2003","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.mce.2011.05.016_b0235","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1210\/jc.2007-0235","article-title":"Total inhibin is a potential serum marker for epithelial ovarian cancer","volume":"92","author":"Tsigkou","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.05.016_b0240","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.fertnstert.2006.11.004","article-title":"Predictors of recovery of ovarian function during weight gain in anorexia nervosa","volume":"87","author":"van Elburg","year":"2007","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.mce.2011.05.016_b0245","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/01.GME.0000123642.76105.6E","article-title":"Anti-Mullerian hormone is a promising predictor for the occurrence of the menopausal transition","volume":"11","author":"van Rooij","year":"2004","journal-title":"Menopause"},{"key":"10.1016\/j.mce.2011.05.016_b0250","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.fertnstert.2004.11.029","article-title":"Serum antiMullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study","volume":"83","author":"van Rooij","year":"2005","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.mce.2011.05.016_b0255","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/j.1471-0528.1999.tb08186.x","article-title":"Serum markers for Down\u2019s syndrome in women who have had in vitro fertilisation: implications for antenatal screening","volume":"106","author":"Wald","year":"1999","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"10.1016\/j.mce.2011.05.016_b0260","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/pd.1446","article-title":"Cross-trimester marker ratios in prenatal screening for Down syndrome","volume":"26","author":"Wald","year":"2006","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.mce.2011.05.016_b0265","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/humupd\/dml021","article-title":"An update on antenatal screening for Down\u2019s syndrome and specific implications for assisted reproduction pregnancies","volume":"12","author":"Weisz","year":"2006","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.mce.2011.05.016_b0270","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1210\/jc.82.8.2645","article-title":"Frequency modulation of follicle-stimulating hormone (FSH) during the luteal\u2013follicular transition: evidence for FSH control of inhibin B in normal women","volume":"82","author":"Welt","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.05.016_b0275","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1210\/jc.84.1.105","article-title":"Female reproductive aging is marked by decreased secretion of dimeric inhibin","volume":"84","author":"Welt","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.05.016_b0280","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00001703-200206000-00012","article-title":"The physiology and pathophysiology of inhibin, activin and follistatin in female reproduction","volume":"14","author":"Welt","year":"2002","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"10.1016\/j.mce.2011.05.016_b0285","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.1210\/jc.2005-0695","article-title":"Follicular arrest in polycystic ovary syndrome is associated with deficient inhibin A and B biosynthesis","volume":"90","author":"Welt","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.05.016_b0290","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1210\/me.2009-0021","article-title":"Endogenous betaglycan is essential for high-potency inhibin antagonism in gonadotropes","volume":"23","author":"Wiater","year":"2009","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2011.05.016_b0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/JOE-08-0549","article-title":"The biology of activin: recent advances in structure, regulation and function","volume":"202","author":"Xia","year":"2009","journal-title":"J. Endocrinol."}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720711002589?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720711002589?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,7]],"date-time":"2024-04-07T09:48:47Z","timestamp":1712483327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720711002589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":59,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0303720711002589"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2011.05.016","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}